BaleDoneen Method to Present Best Practices for Heart Attack and Stroke Prevention in New Orleans

BaleDoneen.com Press Releases

NEW ORLEANS and SPOKANE, Wash., Oct. 26, 2017 /PRNewswire/ — Every 43 seconds, someone in the U.S. has a heart attack, and every four minutes, an American dies from a stroke. On November 2-4, the BaleDoneen Method (BDM) will convene leading experts to discuss best practices to prevent these catastrophes at its 10th Annual Reunion of graduates of its Preceptorship Course. Read more here: https://www.prnewswire.com/news-releases/baledoneen-method-to-present-best-practices-for-heart-attack-and-stroke-prevention-in-new-orleans-300543817.html

BaleDoneen: Inflammation – our side of the story! – Arteriology and Inflammation

BaleDoneen.com General News, Press Releases

Understanding the mechanism from which heart attack or ischemic stroke occurs allows for an appreciation of the connection between inflammation, disease and vascular events.  Atherosclerotic plaque lesions develop silently within the artery wall, often with minimal luminal encroachment.  When an artery wall weakens due to an influx of inflammation, the protective endothelial lining can rupture or erode, thus exposing the …

BaleDoneen Method Statement Regarding Panasonic’s CardioHealth Carotid IMT Device

BaleDoneen.com General News, Press Releases

A BaleDoneen clinical review of our brief experience with CardioHealthIMT imaging. The purpose of this statement is to provide our impressions of the CardioHealth carotid IMT imaging system from our perspective, based on a decade of clinical use of CIMT.  CardioHealth recently introduced their machine into the US market.  This has generated lots of excitement and interest from many of …

BaleDoneen Method Statement Regarding Panasonic’s CardioHealth Carotid IMT Device

BaleDoneen.com General News, Press Releases

A BaleDoneen clinical review of our brief experience with CardioHealthIMT imaging. The purpose of this statement is to provide our impressions of the CardioHealth carotid IMT imaging system from our perspective, based on a decade of clinical use of CIMT. CardioHealth recently introduced their machine into the US market. This has generated lots of excitement and interest from many of …

BaleDoneen Thoughts – Pioglitazone (Actos) and Bladder Cancer

BaleDoneen.com General News, Press Releases

The French drug regulatory authority (AFSSAPS) has called a halt to all formal marketing of pioglitazone (Actos) and is recommending that physicians should not prescribe any more drugs containing pioglitazone.  They have made these statements based on a signal that pioglitazone may be associated with a small increase in bladder cancer in diabetics, suggesting that the risk of bladder cancer …

AIM-HIGH study release – BaleDoneen Response

BaleDoneen.com General News, Press Releases

NHLBI announced that the AIM-HIGH study has been stopped.  AIM-HIGH, a randomized, multicenter clinical trial sponsored by the NHLBI was designed to answer the question of whether raising high-density lipoprotein cholesterol (HDL-C) in patients with a history of stable, non-acute pre-existing cardiovascular disease and well controlled low-density lipoprotein cholesterol (LDL-C) would lower the rate of CV events. All AIM-HIGH participants …

President Clinton’s recidivistic disease

BaleDoneen.com Press Releases

The following article was printed yesterday regarding President Bill Clinton’s recidivistic event.  We feel it necessary to comment on Dr. Yancy’s statements below. Clinton undergoes angioplasty Doctors say former president, who underwent a quadruple bypass in September 2004, had a clogged artery. BY DEEPTI HAJELA AND MARILYNN MARCHIONE THE ASSOCIATED PRESS Two stents resembling tiny mesh scaffolds were placed inside …